ERBB2 and breast carcinoma: In this study, we examined expression of AR and VDR, phosphorylation of AKT Ser473 (AKT phospho-Ser473) and ERα Ser167 (ERα phospho-Ser167), and the mutational status of the PIK3CA gene in ER-positive, HER2-negative early breast cancer tissues.